Drug Profile
Research programme: transdermal polio vaccine - Corium International
Latest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Corium International
- Class Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Poliomyelitis
Most Recent Events
- 28 Dec 2018 No recent reports of development identified for research development in Poliomyelitis(Prevention) in USA (Transdermal, Patch)
- 17 Dec 2018 Corium International has been acquired by Gurnet point capital
- 17 Nov 2014 Early research in Poliomyelitis (Prevention) in USA (Transdermal)